In parallel with these encouraging results, Tiziana Life Sciences has initiated a randomized, double-blind, placebo-controlled Phase 2 clinical trial to further assess the efficacy and safety of nasal ...

Researchers used AI models to design antibodies that neutralize over 1,300 SARS-CoV-2 strains, including Delta and Omicron.

Participants in the CLL11 trial and a smaller group of patients followed after study completion showed improved overall ...

The FDA has approved a monoclonal antibody to treat individuals aged 12 years and older with generalized myasthenia gravis ...

The FDA approved nipocalimab (Imaavy) injection to treat adults and children ages 12 and older with generalized myasthenia gravis (gMG) who are anti-acetylcholine receptor (AChR) or ...

MoonLake Immunotherapeutics to host a Capital Markets Day on Tuesday, April 29 ...

• There is not enough evidence to determine the best method for preventing haemolytic uraemic syndrome (HUS) in patients with Shiga toxin-producing Escherichia coli (STEC)-associated diarrhoea. • More ...

Antibodies are best known for their ability to latch onto and neutralize bacteria, viruses and other pathogens. But these immune proteins can do more than that: They also activate other components of ...

Like the name says, antisperm antibodies fight sperm. It happens when the immune system mistakenly targets sperm in a man’s semen as an invader and damages or kills it. Antisperm antibodies aren ...

BigHat Biosciences, a Californian biotech with a machine learning (ML)-guided antibody discovery and development platform, has announced a strategic collaboration with US pharma major Eli Lilly (NYSE: ...